 |
 |
Goodman & Gilman's The Pharmacological Basis of Therapeutics, 11e
Laurence L. Brunton, editor-in-chief
John S. Lazo and Keith L. Parker, Associate Editors
Editors of the online edition:
Laurence L. Brunton, editor-in-chief
Associate Editors: Keith L. Parker, Nelda Murri, Donald K. Blumenthal, and Björn C. Knollmann
In Memoriam
We are sad to report the death of our colleague and friend, Keith Parker. He will always be remembered for his energy, breadth of knowledge, and sparkling ideas. Memorial contributions may be made to endocrinology research at the Keith L. Parker Fund, UT Southwestern Medical Center, P.O. Box 910888, Dallas, Texas 75391-0888.
|
Preface Preface to the Online Edition Copyright Contributors
CONTENTS
| I. General Principles |
| Chapter 1. | Pharmacokinetics and Pharmacodynamics: The Dynamics of Drug Absorption, Distribution, Action, and Elimination |
| Chapter 2. | Membrane Transporters and Drug Response |
| Chapter 3. | Drug Metabolism
Latest Update: |
| Chapter 4. | Pharmacogenetics
Latest Update: |
| Chapter 5. | The Science of Drug Therapy
Latest Update: |
II. Drugs Acting at Synaptic and Neuroeffector Junctional Sites |
| Chapter 6. | Neurotransmission: The Autonomic and Somatic Motor Nervous Systems
Multimedia:
Multimedia: |
| Chapter 7. | Muscarinic Receptor Agonists and Antagonists |
| Chapter 8. | Anticholinesterase Agents |
| Chapter 9. | Agents Acting at the Neuromuscular Junction and Autonomic Ganglia |
| Chapter 10. | Adrenergic Agonists and Antagonists |
| Chapter 11. | 5-Hydroxytryptamine (Serotonin): Receptor Agonists and Antagonists |
III. Drugs Acting on the Central Nervous System |
| Chapter 12. | Neurotransmission and the Central Nervous System |
| Chapter 13. | General Anesthetics |
| Chapter 14. | Local Anesthetics |
| Chapter 15. | Therapeutic Gases: Oxygen, Carbon Dioxide, Nitric Oxide, and Helium |
| Chapter 16. | Hypnotics and Sedatives |
| Chapter 17. | Drug Therapy of Depression and Anxiety Disorders
Latest Update: |
| Chapter 18. | Pharmacotherapy of Psychosis and Mania |
| Chapter 19. | Pharmacotherapy of the Epilepsies
Multimedia: |
| Chapter 20. | Treatment of Central Nervous System Degenerative Disorders
Multimedia: |
| Chapter 21. | Opioid Analgesics |
| Chapter 22. | Ethanol |
| Chapter 23. | Drug Addiction and Drug Abuse |
IV. Autacoids: Drug Therapy of Inflammation |
| Chapter 24. | Histamine, Bradykinin, and Their Antagonists |
| Chapter 25. | Lipid-Derived Autacoids: Eicosanoids and Platelet-Activating Factor |
| Chapter 26. | Analgesic-Antipyretic and Antiinflammatory Agents; Pharmacotherapy of Gout |
| Chapter 27. | Pharmacotherapy of Asthma |
V. Drugs Affecting Renal and Cardiovascular Function |
| Chapter 28. | Diuretics |
| Chapter 29. | Vasopressin and Other Agents Affecting the Renal Conservation of Water |
| Chapter 30. | Renin and Angiotensin
Latest Update: |
| Chapter 31. | Treatment of Myocardial Ischemia |
| Chapter 32. | Therapy of Hypertension
Latest Update: |
| Chapter 33. | Pharmacotherapy of Congestive Heart Failure
Latest Update:
Multimedia: |
| Chapter 34. | Antiarrhythmic Drugs
Latest Update:
Multimedia:
Multimedia:
Multimedia:
Multimedia: |
| Chapter 35. | Drug Therapy for Hypercholesterolemia and Dyslipidemia |
VI. Drugs Affecting Gastrointestinal Function |
| Chapter 36. | Pharmacotherapy of Gastric Acidity, Peptic Ulcers, and Gastroesophageal Reflux Disease |
| Chapter 37. | Treatment of Disorders of Bowel Motility and Water Flux; Antiemetics; Agents Used in Biliary and Pancreatic Disease |
| Chapter 38. | Pharmacotherapy of Inflammatory Bowel Disease
Latest Update: |
VII. Chemotherapy of Parasitic Infections |
| Chapter 39. | Chemotherapy of Protozoal Infections: Malaria
Latest Update: |
| Chapter 40. | Chemotherapy of Protozoal Infections: Amebiasis, Giardiasis, Trichomoniasis, Trypanosomiasis, Leishmaniasis, and Other Protozoal Infections |
| Chapter 41. | Chemotherapy of Helminth Infections |
VIII. Chemotherapy of Microbial Diseases |
| Chapter 42. | General Principles of Antimicrobial Therapy |
| Chapter 43. | Sulfonamides, TrimethoprimSulfamethoxazole, Quinolones, and Agents for Urinary Tract Infections |
| Chapter 44. | Penicillins, Cephalosporins, and Other -Lactam Antibiotics |
| Chapter 45. | Aminoglycosides |
| Chapter 46. | Protein Synthesis Inhibitors and Miscellaneous Antibacterial Agents
Latest Update: |
| Chapter 47. | Chemotherapy of Tuberculosis, Mycobacterium avium Complex Disease, and Leprosy
Latest Update: |
| Chapter 48. | Antimicrobial Agents: Antifungal Agents |
| Chapter 49. | Antiviral Agents (Nonretroviral) |
| Chapter 50. | Antiretroviral Agents and Treatment of HIV Infection
Latest Update: |
IX. Chemotherapy of Neoplastic Diseases |
| Chapter 51. | Antineoplastic Agents
Latest Update: |
X. Drugs Used for Immunomodulation |
| Chapter 52. | Immunosuppressants, Tolerogens, and Immunostimulants
Latest Update: |
XI. Drugs Acting on the Blood and the Blood-Forming Organs |
| Chapter 53. | Hematopoietic Agents: Growth Factors, Minerals, and Vitamins
Latest Update: |
| Chapter 54. | Blood Coagulation and Anticoagulant, Thrombolytic, and Antiplatelet Drugs
Latest Update:
Multimedia:
Multimedia:
Multimedia:
Multimedia: |
XII. Hormones and Hormone Antagonists |
| Chapter 55. | Pituitary Hormones and Their Hypothalamic Releasing Hormones |
| Chapter 56. | Thyroid and Antithyroid Drugs |
| Chapter 57. | Estrogens and Progestins |
| Chapter 58. | Androgens |
| Chapter 59. | Adrenocorticotropic Hormone; Adrenocortical Steroids and Their Synthetic Analogs; Inhibitors of the Synthesis and Actions of Adrenocortical Hormones |
| Chapter 60. | Insulin, Oral Hypoglycemic Agents, and the Pharmacology of the Endocrine Pancreas |
| Chapter 61. | Agents Affecting Mineral Ion Homeostasis and Bone Turnover |
XIII. Dermatology |
| Chapter 62. | Dermatological Pharmacology |
XIV. Ophthalmology |
| Chapter 63. | Ocular Pharmacology |
XV. Toxicology |
| Chapter 64. | Principles of Toxicology and Treatment of Poisoning |
| Chapter 65. | Heavy Metals and Heavy-Metal Antagonists |
Appendices |
| Appendix I. | Principles of Prescription Order Writing and Patient Compliance |
| Appendix II. | Design and Optimization of Dosage Regimens: Pharmacokinetic Data |
|
 |
|
Goodman & Gilman's
Online Features
|
Note from the Editors
In the coming months, Goodman and Gilman's will focus on pediatric pharmacology,
with a Grand Rounds lecture
by Robert M. Ward and a series of updates from Marcel
J. Casavant and Jill R.K. Griffith.
|
Grand Rounds View all
|
Animations
Flash Player 8 or higher required (Get Flash)
Hemostasis: Antiplatelet, Anticoagulant, and Thrombolytic Drugs:
Cardiac Electrophysiology and Pharmacology:
Neuropharmacology:
|
|
|